Effectiveness and Safety of Upadacitinib Induction Therapy in Real-World Setting for 234 Patients with Crohn's Disease: A GETAID Multicentre Cohort Study

被引：0

作者：

Richard, N. ^{[1
]}

Amiot, A. ^{[2
]}

Seksik, P. ^{[3
]}

Altwegg, R. ^{[4
]}

Laharie, D. ^{[5
]}

Vuitton, L. ^{[6
]}

Nachury, M. ^{[7
]}

Nancey, S. ^{[8
]}

Bouguen, G. ^{[9
]}

Gilletta, C. ^{[10
]}

Rouillon, C. ^{[11
]}

Coffin, B. ^{[12
]}

Allez, M. ^{[13
]}

Buisson, A. ^{[14
]}

Le Berre, C. ^{[15
]}

Pelletier, A. L. ^{[16
]}

Uzzan, M. ^{[17
]}

Caillo, L. ^{[18
]}

Sickersen, G. ^{[19
]}

Hupe, M. ^{[20
]}

Abitbol, V ^{[21
]}

Vidon, M. ^{[22
]}

Goutorbe, F. ^{[23
]}

Amil, M. ^{[24
]}

Brixi, H. ^{[25
]}

Benezech, A. ^{[26
]}

Kwiatek, S. ^{[27
]}

Peyrin-Biroulet, L. ^{[28
]}

Fumery, M. ^{[29
]}

机构：

[1] Univ Rouen Normandie, INSERM, ADEN UMR1073, Nutr Inflammat & Microbiota Gut Brain Axis, F-76000 Rouen, France

[2] Univ Paris Saclay, AP HP, Hop Bicetre, Serv Gynecol Obstet, Paris, France

[3] Sorbonne Univ, Hop St Antoine, CRSA,INSERM,APHP, Dept Gastroenterol, Paris, France

[4] CHU Montpellier, Dept Gastroenterol, Montpellier, France

[5] Univ Bordeaux, CHU Bordeaux, Dept Gastroenterol, Hop Haut Leveque,INSERM CIC 1401, Bordeaux, France

[6] Univ Franche Comte, UMR 1098, F-25000 Besancon, France

[7] Univ Lille, INSERM, CHU Lille, U1286 INFIN Inst Translat Res Inflammat, Lille, France

[8] CHU Lyon, Dept Gastroenterol, Lyon, France

[9] Univ Rennes, Inst NuMeCan Nutr Metab & Canc, INSERM, CHU Rennes,Inrae, Rennes, France

[10] CHU Toulouse Rangueil, Dept Gastroenterol & Pancreatol, F-31059 Toulouse, France

[11] Univ Hosp, Dept Nephrol, Caen, France

[12] Hop Louis Mourier, AP HP, Serv Chirurg, Colombes, France

[13] Hop St Louis, Inst Univ Hematol, INSERM, U1160, Paris, France

[14] Univ Clermont Auvergne, Inserm U1071, M2iSH Usc INRA 2018, Clermont Ferrand, France

[15] Nantes Univ, Inst Malad Appareil Digest IMAD, Hepato Gastro Enterol & Assistance Nutr, CHU Nantes,INSERM CIC 1413, Nantes, France

[16] Bichat Claude Bernard Univ Hosp, APHP, Dept Radiol, F-75018 Paris, France

[17] Paris Est Creteil Univ UPEC, Henri Mondor Hosp, APHP, Dept Gastroenterol, Creteil, France

[18] Univ Nimes Hosp, Dept Cardiol, Nimes, France

[19] Univ Poitiers Hosp, Dept Bacteriol, Poitiers, France

[20] Univ Grenoble Alpes, CHU Grenoble Alpes, Hepatogastroenterol & Digest Oncol Dept, CNRS,UMR 5309,INSERM,U1209,Inst Adv Biosci, Grenoble, France

[21] Cochin Univ Hosp, AP HP, Gastroenterol Dept, Paris, France

[22] Ctr Hospitalier Intercommunal Creteil, Pneumol Dept, Creteil, France

[23] Hosp Bayonne, Dept Gastroenterol, Bayonne, France

[24] Hosp La Roche Sur Yon, Dept Gastroenterol, La Roche La Yon, France

[25] Univ Hosp, Dept Pathol, Reims, France

[26] Avignon Hosp, Dept Gastroenterol, F-84000 Avignon, France

[27] St Etienne Univ Hosp, Dept Gastroenterol, St Etienne, France

[28] Univ Lorraine, INSERM, NGERE, IHU INFINY, Nancy, France

[29] Univ Picardie, Amiens Univ Hosp, Dept Gastroenterol, PeriTox, Amiens, France

来源：

JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷

关键词：

D O I：

10.1093/ecco-jcc/jjae190.1230

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P1056

引用

页码：i1948 / i1950

页数：3

共 50 条

[1] Effectiveness and Safety of Induction Therapy with Upadacitinib for the Treatment of Perianal Crohn's Disease : Real-World Data from a GETAID Multicentre Cohort Study
Richard, N.
Altwegg, R.
Seksik, P.
Nancey, S.
Nachury, M.
Laharie, D.
Amiot, A.
Vuitton, L.
Peyrin-Biroulet, L.
Allez, M.
Rouillon, C.
Coffin, B.
Pelletier, A. L.
Uzzan, M.
Amil, M.
Hupe, M.
Fumery, M.
Bozon, A.
JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1225 - I1227
[2] Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort Study
Richard, Nicolas
Amiot, Aurelien
Seksik, Philippe
Altwegg, Romain
Laharie, David
Vuitton, Lucine
Nachury, Maria
Bouguen, Guillaume
Nancey, Stephane
Gilletta, Cyrielle
Rouilon, Clea
Coffin, Benoit
Allez, Matthieu
Buisson, Anthony
Le Berre, Catherine
Uzzan, Mathieu
Caillo, Ludovic
Pelletier, Anne-Laure
Peyrin-Biroulet, Laurent
Fumery, Mathurin
GETAID
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025,
[3] Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: a GETAID multicentre cohort study
Fumery, M.
Defrance, A.
Roblin, X.
Altwegg, R.
Caron, B.
Hebuterne, X.
Carmen, S.
Meyer, A.
Nachury, M.
Laharie, D.
Nancey, S.
Le Berre, C.
Serrero, M.
Geyl, S.
Gilletta, C.
Soune, P. Ah
Duveau, N.
Uzza, M.
Abitbol, V.
Biron, A.
Minh, M. L. Tran
Paupard, T.
Vuitton, L.
Elgharabawy, Y.
Peyrin-Biroulet, L.
JOURNAL OF CROHNS & COLITIS, 2023, 17 : 770 - 770
[4] Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort study
Fumery, Mathurin
Defrance, Antoine
Roblin, Xavier
Altwegg, Romain
Caron, Benedicte
Hebuterne, Xavier
Stefanescu, Carmen
Meyer, Antoine
Nachury, Maria
Laharie, David
Nancey, Stephane
Le Berre, Catherine
Serrero, Melanie
Geyl, Sophie
Giletta, Cyrielle
Ah-Soune, Philippe
Duveau, Nicolas
Uzzan, Mathieu
Abitbol, Vered
Biron, Amelie
My-Linh Tran-Minh
Paupard, Thierry
Vuitton, Lucine
Elgharabawy, Yasmine
Peyrin-Biroulet, Laurent
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (04) : 426 - 434
[5] REAL-WORLD EFFECTIVENESS OF UPADACITINIB IN CROHN'S DISEASE; A UK MULTICENTRE RETROSPECTIVE COHORT STUDY
Elford, Alexander T.
Bishara, Maria
Plevris, Nikolas
Gros, Beatriz
Constantine-Cooke, Nathan
Goodhand, James
Kennedy, Nicholas A.
Ahmad, Tariq
Lees, Charlie W.
GASTROENTEROLOGY, 2024, 166 (05) : S1451 - S1452
[6] Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study
Amiot, Aurelien
Filippi, Jerome
Abitbol, Vered
Cadiot, Guillaume
Laharie, David
Serrero, Melanie
Altwegg, Romain
Bouhnik, Yoram
Peyrin-Biroulet, Laurent
Gilletta, Cyrielle
Roblin, Xavier
de Chambrun, Guillaume Pineton
Vuitton, Lucine
Bourrier, Anne
Nancey, Stephane
Gornet, Jean-Marc
Nahon, Stephane
Bouguen, Guillaume
Viennot, Stephanie
Pariente, Benjamin
Fumery, Mathurin
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (11) : 1039 - 1046
[7] Real-world effectiveness of upadacitinib in Crohn's disease; a UK multicentre retrospective cohort study
Elford, A.
Bishara, M.
Plevris, N.
Gros, B.
Constantine-Cooke, N.
Goodhand, J.
Kennedy, N.
Ahmad, T.
Lees, C.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1523 - I1525
[8] Real-world effectiveness of upadacitinib in Crohn's disease: a UK multicentre retrospective cohort study
Elford, Alexander Thomas
Bishara, Maria
Plevris, Nikolas
Gros, Beatriz
Constantine-Cooke, Nathan
Goodhand, James
Kennedy, Nicholas A.
Ahmad, Tariq
Lees, Charlie W.
FRONTLINE GASTROENTEROLOGY, 2024, 15 (04) : 297 - 304
[9] REAL-WORLD EFFECTIVENESS AND SAFETY OF UPADACITINIB IN CROHN'S DISEASE: A MULTICENTER STUDY
Devi, Jalpa
Chowla, Navreet M.
Khan, Abdul
Huang, Katherine
Reddy, Nikhil
Pekow, Joel
Patel, Anish
Bishu, Shrinivas
Shukla, Richa
Fenster, Marc
Ungaro, Ryan C.
Yarur, Andres
Johnson, Amanda M.
Deepak, Parakkal
GASTROENTEROLOGY, 2024, 166 (05) : S1452 - S1452
[10] Effectiveness and safety of ustekinumab induction therapy in ulcerative colitis: A GETAID real-world cohort study
Amiot, A.
Vered, A.
Filippi, J.
Cadiot, G.
Laharie, D.
Melanie, S.
Altwegg, R.
Bouhnik, Y.
Peyrin-biroulet, L.
Gilletta, C.
Roblin, X.
de Chambrun, G. Pineton
Vuitton, L.
Bourrier, A.
Nancey, S.
Gornet, J. M.
Nahon, S.
Bouguen, G.
Viennot, S.
Benjamin, P.
Fumery, M.
JOURNAL OF CROHNS & COLITIS, 2020, 14 : S579 - S579

← 1 2 3 4 5 →